Alerts will be sent to your verified email
Verify Email
INNOVACAP
|
Innova Captab
|
Suven Life Sciences
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.73 % | -82.05 % | 18.02 % |
|
5yr average Equity Multiplier
|
2.34 | 1.55 | 1.97 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.05 | 1.09 |
|
5yr Avg Net Profit Margin
|
8.55 % | -1150.51 % | 8.24 % |
|
Price to Book
|
4.21 | 15.07 | 2.88 |
|
P/E
|
34.56 | 0.0 | 21.26 |
|
5yr Avg Cash Conversion Cycle
|
31.3 Days | 97.84 Days | 79.88 Days |
|
Inventory Days
|
52.34 Days | 10.88 Days | 69.48 Days |
|
Days Receivable
|
89.43 Days | 71.91 Days | 111.3 Days |
|
Days Payable
|
105.42 Days | 3.38 Days | 97.75 Days |
|
5yr Average Interest Coverage Ratio
|
22.73 | -373.47 | 9.61 |
|
5yr Avg ROCE
|
21.99 % | -82.34 % | 21.16 % |
|
5yr Avg Operating Profit Margin
|
13.36 % | -1227.3 % | 14.01 % |
|
5 yr average Debt to Equity
|
0.55 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
30.09 % | 17.38 % | -9.72 % |
|
5yr Average Return on Assets
|
8.63 % | -54.63 % | 9.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 67.36 % | 54.72 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.38 % | -5.05 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.29 % | 2.07 % | 6.73 % |
|
Innova Captab
|
Suven Life Sciences
|
Aarti Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|